These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9547434)

  • 1. The analysis of small-sample multivariate data.
    Saranadasa H; Altan S
    J Biopharm Stat; 1998 Mar; 8(1):163-86. PubMed ID: 9547434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multivariate two-sample mean test for small sample size and missing data.
    Wu Y; Genton MG; Stefanski LA
    Biometrics; 2006 Sep; 62(3):877-85. PubMed ID: 16984331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tests for inter-subject and total variabilities under crossover designs.
    Lee Y; Shao J; Chow SC; Wang H
    J Biopharm Stat; 2002 Nov; 12(4):503-34. PubMed ID: 12477072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Power of pairwise comparisons in the equal variance and unequal sample size case.
    Ramsey PH; Ramsey PP
    Br J Math Stat Psychol; 2008 May; 61(Pt 1):115-31. PubMed ID: 18482478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large sample tests for binary outcomes in fixed-dose combination drug studies.
    Wang SJ; Hung HM
    Biometrics; 1997 Jun; 53(2):498-503. PubMed ID: 9192448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varying cluster sizes in trials with clusters in one treatment arm: sample size adjustments when testing treatment effects with linear mixed models.
    Candel MJ; Van Breukelen GJ
    Stat Med; 2009 Aug; 28(18):2307-24. PubMed ID: 19472169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A method for comparing two normal means using combined samples of correlated and uncorrelated data.
    Looney SW; Jones PW
    Stat Med; 2003 May; 22(9):1601-10. PubMed ID: 12704618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample size planning with the cost constraint for testing superiority and equivalence of two independent groups.
    Guo JH; Chen HJ; Luh WM
    Br J Math Stat Psychol; 2011 Nov; 64(3):439-61. PubMed ID: 20704777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Group sequential t-test for clinical trials with small sample sizes across stages.
    Shao J; Feng H
    Contemp Clin Trials; 2007 Sep; 28(5):563-71. PubMed ID: 17434814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sample size calculations for population pharmacodynamic experiments involving repeated dichotomous observations.
    Ogungbenro K; Aarons L
    J Biopharm Stat; 2008; 18(6):1212-27. PubMed ID: 18991118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Test equality and sample size calculation based on risk difference in a randomized clinical trial with noncompliance and missing outcomes.
    Lui KJ; Chang KC
    Biom J; 2008 Apr; 50(2):224-36. PubMed ID: 18264992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes.
    Lui KJ; Chang KC
    Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sample size determination based on rank tests in clinical trials.
    Wang H; Chen B; Chow SC
    J Biopharm Stat; 2003 Nov; 13(4):735-51. PubMed ID: 14584719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonparametric comparison for panel count data with unequal observation processes.
    Zhao X; Sun J
    Biometrics; 2011 Sep; 67(3):770-9. PubMed ID: 21114659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of adaptive two-stage double-arm clinical trials for dichotomous variables.
    Jiang Z; Xue F; Li C; Wang L; Cai H; Zhang C; Xia J
    Contemp Clin Trials; 2010 May; 31(3):242-50. PubMed ID: 20172053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical usage of O'Brien's OLS and GLS statistics in clinical trials.
    Dallow NS; Leonov SL; Roger JH
    Pharm Stat; 2008; 7(1):53-68. PubMed ID: 17390306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting data fabrication in clinical trials from cluster analysis perspective.
    Wu X; Carlsson M
    Pharm Stat; 2011; 10(3):257-64. PubMed ID: 20936626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size re-estimation in group-sequential response-adaptive clinical trials.
    Morgan CC
    Stat Med; 2003 Dec; 22(24):3843-57. PubMed ID: 14673942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample size calculation for the van Elteren test adjusting for ties.
    Zhao YD; Rahardja D; Mei Y
    J Biopharm Stat; 2008; 18(6):1112-9. PubMed ID: 18991111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance and sample size requirements of Bayesian methods for binary outcomes in fixed-dose combination drug studies.
    Holt MM; Stamey JD; Seaman JW; Young DM
    J Biopharm Stat; 2009; 19(1):120-32. PubMed ID: 19127471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.